Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nexol Venture Capital is a South Korean venture capital firm specializing in early-stage investments within the life sciences, healthcare, and information technology sectors. Founded in 2018 and headquartered in Seoul, the firm focuses on identifying high-growth potential startups that leverage innovative technologies to address unmet medical needs and digital transformation. Nexol VC provides strategic guidance and networking opportunities to its portfolio companies, which include various biotech, medtech, and AI-driven drug discovery innovators. The firm plays a significant role in the Korean startup ecosystem by bridging the gap between research-driven science and commercial success. Its investment strategy often targets the convergence of biology and ICT, supporting companies that utilize data-driven approaches to healthcare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nexol Venture Capital.